Genentech
Genentech was the lab’s first industrial co-author. Prompted by Rami Hannoush, the lab built a scalable route to the marine alkaloid haouamine A, and Genentech showed that it and its atropisomer are active against prostate cancer cells.
South San Francisco, California · A member of the Roche Group
- Papers together
- 1
- Years
- 2009
- Co-authors
- 2
The record
Our paper with Genentech
-
Scalable Total Synthesis and Biological Evaluation of Haouamine A and Its Atropisomer
- Genentech Irina N. Krylova, Rami N. Hannoush
No papers match these filters.
Our co-authors at Genentech
Rami N. Hannoush · Irina N. Krylova
Keep exploring
More partners
Enamine
HitGen Hongene Biotech Hongene Biotech IKA IKA InduPro Therapeutics InduPro Therapeutics
KULR Technology RQx Pharmaceuticals RQx Pharmaceuticals Socrates Biosciences Socrates Biosciences The Medicines Company The Medicines Company Work with us
Interested in collaborating with the Baran lab?
If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.
Email Philor write to pbaran@scripps.edu